From Surf Wiki (app.surf) — the open knowledge base

Danco Laboratories

American pharmaceutical distributor

Summary

American pharmaceutical distributor

Field	Value
name	Danco Laboratories
location	New York, United States
area_served	United States
industry	Pharmaceutical
products	mifepristone
website

Danco Laboratories is a pharmaceutical distributor located in midtown Manhattan which distributes the abortifacient drug mifepristone under the brand name Mifeprex. Mifeprex is the only drug distributed by Danco, although the company plans to expand to other drugs in the future.

Danco is a private company that does not disclose the names of its investors, but stated that "[Investors] included wealthy individuals and foundations that supported abortion rights."

Outside the United States, mifepristone is distributed by the French pharmaceutical company Exelgyn, under the trade name Mifegyne.

History

On 16 May 1994, Roussel-Uclaf announced it was donating without remuneration all rights for medical uses of mifepristone in the United States to the Population Council, which would then sponsor clinical trials for mifepristone between September 1994 and September 1995. In September 1995, The Population Council licensed mifepristone to Danco Laboratories and entered into a manufacturing agreement with Hungarian drug manufacturer Gedeon Richter. In 1996, the US Food and Drug Administration (FDA) conditionally licensed RU-486 for early trimester abortion, pending a resolution on some remaining technical and manufacturing issues.

In 1997, Gideon Richter withdrew from efforts to manufacture mifepristone in the United States following opposition from pro-life groups, which led to Danco filing a breach of contract lawsuit.

On September 28, 2000, Danco Laboratories received approval to distribute mifepristone (under the Mifeprex brand name) from the US Food and Drug Administration (FDA).

Danco had exclusive sales rights in the United States until 2019, when GenBioPro obtained approval to sell a generic version of mifepristone."Generic abortion pill manufacturer sues FDA in effort to preserve access" Sarah McCammon April 19, 2023 NPR https://www.npr.org/2023/04/19/1170806176/abortion-pill-mifepristone-supreme-court-fda-generic-genbiopro

References

"How A Drugmaker Turned The Abortion Pill Into A Rare-Disease Profit Machine". Washington Post.
Rutherford, Fiona. (2023-04-14). "Why you’ve never heard of the company behind the abortion pill".
(17 May 1994). "Accord opens way for abortion pill in U.S. in 2 years". The New York Times.
(20 March 1998). "Abortion, revised: participants in the U.S. clinical trials evaluate mifepristone". Social Science & Medicine.
(July 27, 2000). "DANCO LABORATORIES LIMITED v. The Washington Post Company, Intervenor-Appellant. (2000)". Supreme Court, Appellate Division, First Department, New York..
(1997-06-12). "ABORTION PILL'S U.S. SPONSOR SUING HUNGARIAN DRUG FIRM". Washington Post.
(29 September 2000). "U.S. approves abortion pill; drug offers more privacy and could reshape debate". The New York Times.

Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

1995-establishments-in-new-york-(state) companies-based-in-new-york-city american-companies-established-in-1995 pharmaceutical-companies-established-in-1995 pharmaceutical-companies-of-the-united-states health-care-companies-based-in-new-york-(state) medication-abortion

Want to explore this topic further?

Ask Mako anything about Danco Laboratories — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report